PExA AB
Develops non-invasive technology for respiratory medicine by analyzing exhaled air.
PEXA B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007412366 (+1 more)
- LEI:
- 5493000H96U6ILH5V269
- Country:
- Sweden
- Address:
- Arvid Wallgrens Backe 20, 413 46 Göteborg
- Website:
- https://pexa.se/en/
Description
PExA AB is a life science company that develops and commercializes a proprietary, non-invasive technology for respiratory medicine. The company's system collects biomaterial from the small, distal airways by capturing and analyzing particles in exhaled air. This method allows for the sampling of Respiratory Tract Lining Fluid (RTLF), enabling the discovery and analysis of early biomarkers. The technology is designed to advance research, facilitate more accurate diagnostics, and support the development of targeted treatments for various lung diseases. PExA provides its research instruments and services to researchers in academia, healthcare, and the pharmaceutical industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PExA AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PExA AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PExA AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-10 | Erik Svante Höjer | Other | Buy | 100,000 | 19,000.00 SEK |
| 2024-11-29 | Bengt Tomas Jan Gustafsson | Other | Buy | 100,000 | 31,600.00 SEK |
Peer Companies
